piracetam has been researched along with Hepatic Veno Occlusive Disease in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Objective The objective of this study was to compare clinical outcomes in children undergoing hematopoietic cell transplantation who received levetiracetam versus those who received phenytoin for the prevention of busulfan-induced seizures." | 7.85 | Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients. ( Floeter, AE; McCune, JS, 2017) |
| "Objective The objective of this study was to compare clinical outcomes in children undergoing hematopoietic cell transplantation who received levetiracetam versus those who received phenytoin for the prevention of busulfan-induced seizures." | 3.85 | Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients. ( Floeter, AE; McCune, JS, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Floeter, AE | 1 |
| McCune, JS | 1 |
1 other study available for piracetam and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.
Topics: Adolescent; Anticonvulsants; Busulfan; Child; Child, Preschool; Female; Graft Rejection; Hematopoiet | 2017 |